Over the last 12 months, OneMedNet insiders reported 6 buys totaling $1.4M and no sales across SEC Form 4 filings.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Kosasa ThomasD·10% | ▲ Buy | 1,449,275 | $0.69 | $1000K | +8.5% | late |
| Jun 23, 2026 | Green AaronChief Executive Officer · O·D | ▲ Buy | 36,650 | $0.57 | $21K | +2% | — |
| Jun 23, 2026 | Yu JeffreyChief Medical Officer · O·D·10% | ▲ Buy | 158,730 | $0.63 | $100K | +1.8% | — |
| Jun 16, 2026 | Yu JeffreyChief Medical Officer · O·D·10% | ▲ Buy | 172,414 | $0.58 | $100K | +2% | — |
| Jun 15, 2026 | Green AaronChief Executive Officer · O·D | ▲ Buy | 55,622 | $0.55 | $31K | +3.1% | 2 tranches |
| Jun 12, 2026 | Kosasa ThomasD·10% | ▲ Buy | 158,730 | $0.63 | $100K | +0.9% | — |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ONMD feed.